Abionyx Pharma Valuation
| ABNX Stock | EUR 1.19 0.02 1.65% |
Today, the firm appears to be overvalued. Abionyx Pharma SA shows a prevailing Real Value of €1.04 per share. The current price of the firm is €1.19. Our model approximates the value of Abionyx Pharma SA from analyzing the firm fundamentals such as Current Valuation of 51.58 M, return on equity of -0.92, and Profit Margin of (1.78) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Abionyx Pharma's price fluctuation is dangerous at this time. Calculation of the real value of Abionyx Pharma SA is based on 3 months time horizon. Increasing Abionyx Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Abionyx Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Abionyx Stock. However, Abionyx Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.19 | Real 1.04 | Hype 1.19 | Naive 1.15 |
The real value of Abionyx Stock, also known as its intrinsic value, is the underlying worth of Abionyx Pharma SA Company, which is reflected in its stock price. It is based on Abionyx Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Abionyx Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Abionyx Pharma SA helps investors to forecast how Abionyx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abionyx Pharma more accurately as focusing exclusively on Abionyx Pharma's fundamentals will not take into account other important factors: Abionyx Pharma Total Value Analysis
Abionyx Pharma SA is presently forecasted to have takeover price of 51.58 M with market capitalization of 52.53 M, debt of 3.9 M, and cash on hands of 8.33 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Abionyx Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
51.58 M | 52.53 M | 3.9 M | 8.33 M |
Abionyx Pharma Investor Information
About 32.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.21. Abionyx Pharma SA had not issued any dividends in recent years. Based on the key measurements obtained from Abionyx Pharma's financial statements, Abionyx Pharma SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Abionyx Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Abionyx Pharma has an asset utilization ratio of 3.09 percent. This suggests that the Company is making €0.0309 for each dollar of assets. An increasing asset utilization means that Abionyx Pharma SA is more efficient with each dollar of assets it utilizes for everyday operations.Abionyx Pharma Ownership Allocation
Abionyx Pharma holds a total of 28.09 Million outstanding shares. Abionyx Pharma SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Abionyx Pharma Profitability Analysis
The company reported the revenue of 675 K. Net Loss for the year was (5.82 M) with profit before overhead, payroll, taxes, and interest of 259 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Abionyx Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Abionyx Pharma and how it compares across the competition.
About Abionyx Pharma Valuation
The stock valuation mechanism determines Abionyx Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Abionyx Pharma. We calculate exposure to Abionyx Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abionyx Pharma's related companies.ABIONYX Pharma SA, a biopharmaceutical company, discovers and develops high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. ABIONYX Pharma SA was founded in 2005 and is based in Labege, France. ABIONYX PHARMA is traded on Paris Stock Exchange in France.
8 Steps to conduct Abionyx Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Abionyx Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Abionyx Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Abionyx Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Abionyx Pharma's revenue streams: Identify Abionyx Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Abionyx Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Abionyx Pharma's growth potential: Evaluate Abionyx Pharma's management, business model, and growth potential.
- Determine Abionyx Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Abionyx Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Abionyx Stock analysis
When running Abionyx Pharma's price analysis, check to measure Abionyx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abionyx Pharma is operating at the current time. Most of Abionyx Pharma's value examination focuses on studying past and present price action to predict the probability of Abionyx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abionyx Pharma's price. Additionally, you may evaluate how the addition of Abionyx Pharma to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |